Loading…
Baxter International Inc. is projected to rise to $32.69 by 2027, a +22% move from its current price of $26.75. BAX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $26.04 | $26.76 | $27.50 | +0.02% |
| Aug 2 | $25.75 | $26.76 | $27.82 | +0.05% |
| Aug 3 | $25.53 | $26.77 | $28.06 | +0.07% |
| Aug 4 | $25.35 | $26.78 | $28.28 | +0.10% |
| Aug 5 | $25.20 | $26.78 | $28.47 | +0.12% |
| Aug 6 | $25.06 | $26.79 | $28.64 | +0.14% |
| Aug 7 | $24.93 | $26.80 | $28.80 | +0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $24.93 | $26.80 | $28.80 | +0.17% |
| Week 2 | $24.24 | $26.84 | $29.72 | +0.34% |
| Week 3 | $23.73 | $26.89 | $30.47 | +0.51% |
| Week 4 | $23.31 | $26.93 | $31.11 | +0.67% |
| Week 5 | $22.96 | $26.98 | $31.70 | +0.84% |
| Week 6 | $22.64 | $27.02 | $32.25 | +1.01% |
| Week 7 | $22.36 | $27.07 | $32.76 | +1.18% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Baxter International Inc. is a healthcare company that provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.
Its products include sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories.
Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand.
Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Baxter International Inc. (BAX) is a healthcare company with a current price of $26.75 and a market cap of $13.82B. It ranks 693 in market capitalization.
The near-term forecast shows a neutral stance for 2026 with an average price of $26.75, followed by bullish momentum in subsequent years as averages rise from 2027 onward. The multi-year view sees substantial upside, with 2030, 2040, and 2050 averages expanding to $55.97, $222.66, and $423.41 respectively, accompanied by rising ROIs.
For perspective, the forecast envisions meaningful upside across the horizon: 2027 average $32.69, 2028 $38.68, 2029 $47.25, 2030 $55.97, with corresponding ROIs of 22.2, 44.6, 76.6, and 109.2. The long-term outlook projects strong growth to 2040 and 2050, with average prices of $222.66 (ROI 732.4) and $423.41 (ROI 1482.8). These figures imply substantial upside versus the current price, though they are estimates and not guarantees.
A major floor 40.9% below — a decisive break under it would weaken the trend.
The nearest floor, 27.5% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 18.3% above — clearing it would confirm fresh momentum.
Key BAX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BAX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $24.33 | Buy | $24.71 | Buy |
| MA 10 | $23.19 | Buy | $23.77 | Buy |
| MA 20 | $22.85 | Buy | $22.92 | Buy |
| MA 50 | $21.09 | Buy | $21.44 | Buy |
| MA 100 | $19.23 | Buy | $20.49 | Buy |
| MA 200 | $19.56 | Buy | $21.03 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 75.92 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 311.39 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.30 | Buy |
| ROC (12) | 22.71 | Buy |
| Bollinger %B (20,2) | 1.32 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.48 | Buy |
| Awesome (5,34) | 2.32 | Buy |
| Ultimate (7,14,28) | 82.42 | Sell |
| Momentum (10) | 3.40 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 25.69 | Buy |
| ADX (14) | 23.89 | Buy |
| ATR (14) | 0.63 | Info |
The 30-day technical picture is bullish in tone. The sentiment is labeled BULLISH, and the RSI(14) is 80, indicating strong near-term upside momentum.
The stock trades above notable moving averages: SMA50 is $21.09 and SMA200 is $19.56, suggesting a constructive short-term trend. Support is identified at $19.39, with resistance at $26.75, framing the current trading range. The 30-day range runs from $22.35 to $32.02, highlighting recent volatility.
Annualized volatility is 50%, underscoring elevated price variability over a 12-month horizon.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $15.80 | $26.75 | $35.15 | 0% | Neutral | |
| $26.07 | $32.69 | $43.34 | +22% | Bullish | |
| $29.99 | $38.68 | $53.24 | +45% | Bullish | |
| $35.79 | $47.25 | $66.96 | +77% | Bullish | |
| $41.54 | $55.97 | $81.29 | +109% | Bullish | |
| $52.91 | $72.63 | $107.76 | +172% | Bullish | |
| $63.09 | $88.13 | $133.27 | +229% | Bullish | |
| $66.75 | $94.77 | $145.83 | +254% | Bullish | |
| $74.29 | $107.13 | $167.49 | +300% | Bullish | |
| $77.14 | $112.89 | $179.12 | +322% | Bullish | |
| $142.29 | $222.66 | $375.85 | +732% | Bullish | |
| $241.10 | $423.41 | $782.04 | +14.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $15.80 | $26.75 | $31.23 | +0.00% |
| August 2026 | $23.37 | $27.42 | $32.93 | +2.51% |
| September 2026 | $23.10 | $27.34 | $33.28 | -0.29% |
| October 2026 | $23.49 | $27.99 | $34.42 | +2.35% |
| November 2026 | $23.91 | $28.64 | $35.53 | +2.34% |
| December 2026 | $23.35 | $28.11 | $35.15 | -1.84% |
Click any year to see its month-by-month BAX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect BAX to range from $15.80 to $35.15 through 2026. The $26.75 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The BAX price prediction for 2027 points to an average of $32.69 (low $26.07, high $43.34) — a potential gain of +22% on today's $26.75. Buyers look set to stay in control over this stretch.
In 2028, BAX is projected to trade between $29.99 and $53.24, averaging $38.68 — a potential gain of +45% from today's $26.75. That is up +18% on the projected 2027 average. Momentum favours further upside here.
Baxter International Inc.'s 2029 outlook centres on $47.25, within a $35.79 to $66.96 range. That is up +22% on the projected 2028 average. That marks a +77% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, BAX could reach as high as $81.29, with a base case around $55.97 and support toward $41.54 — roughly +109% from $26.75. Momentum favours further upside here.
Expect BAX to range from $52.91 to $107.76 through 2031. The $72.63 average target implies a +172% move from current prices. That is up +30% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The BAX price prediction for 2032 points to an average of $88.13 (low $63.09, high $133.27) — a potential gain of +229% on today's $26.75. Momentum favours further upside here.
In 2033, BAX is projected to trade between $66.75 and $145.83, averaging $94.77 — a potential gain of +254% from today's $26.75. That is up +8% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Baxter International Inc.'s 2034 outlook centres on $107.13, within a $74.29 to $167.49 range. That is up +13% on the projected 2033 average. That marks a +300% change versus current levels. Momentum favours further upside here.
By 2035, BAX could reach as high as $179.12, with a base case around $112.89 and support toward $77.14 — roughly +322% from $26.75. Buyers look set to stay in control over this stretch.
Expect BAX to range from $142.29 to $375.85 through 2040. The $222.66 average target implies a +732% move from current prices. That is up +97% on the projected 2035 average. Momentum favours further upside here.
The BAX price prediction for 2050 points to an average of $423.41 (low $241.10, high $782.04) — a potential gain of +14.8x on today's $26.75. Buyers look set to stay in control over this stretch.
Investing $1,000 in BAX today (≈ 37.383178 BAX) could be worth
$15,828.36
+$14,828.36 (+1483%) by 2050 · US Dollar
Based on the average projected BAX price of $423.41 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BAXwould be worth at today's price.
$1,000 invested in BAX on Jul 30, 2025 (≈ 35.650625 BAX) would be worth
$953.65
-$46.35 (-4.6%) today · 0.95× · US Dollar
Based on a BAX entry price of $28.05 vs. today's $26.75.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $21.67 | $1,234.43 | +23.4% |
| 1 month ago | $21.32 | $1,254.69 | +25.5% |
| 3 months ago | $17.21 | $1,554.33 | +55.4% |
| 6 months ago | $20.07 | $1,332.84 | +33.3% |
| 1 year ago | $28.05 | $953.65 | -4.6% |
| All time (5.0y) ago | $77.21 | $346.46 | -65.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BAX forecast.
Our base-case forecast reaches $54.00 around 2030.
Implied market cap at $54.00: $27.89B
The multi-year forecast illustrates a pronounced upside trajectory with several milestone years. In 2030, the forecast shows min $41.54, avg $55.97, max $81.29, with ROI 109.2 and a bullish sentiment. In 2040, the forecast expands to min $142.29, avg $222.66, max $375.85, with ROI 732.4 and a bullish sentiment.
By 2050, the forecast projects min $241.10, avg $423.41, max $782.04, with ROI 1482.8 and a bullish sentiment.
These figures signal substantial potential appreciation over the longer horizon, driven by the assumed continuation of growth in the company’s healthcare portfolio and related services, while recognizing that forecasts are inherently uncertain and not guaranteed.
The path from 2026 through 2050 depicts a transition from a neutral near term to a strongly bullish longer-term outlook, with the most pronounced gains appearing in the 2040s and beyond.
Tap a question to reveal the answer.
2030 min $41.54, avg $55.97, max $81.29; ROI 109.2; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward, with rising averages: 2027 avg $32.69, ROI 22.2; 2028 avg $38.68, ROI 44.6; 2029 avg $47.25, ROI 76.6; 2030 avg $55.97, ROI 109.2. The long-term view also shows strong upside in 2040 (avg $222.66, ROI 732.4) and 2050 (avg $423.41, ROI 1482.8). These are estimates, not guarantees.
Yes. The forecast shows 2033 avg $94.77 and 2034 avg $107.13, with 2033 min $66.75 and max $145.83 and 2034 min $74.29 and max $167.49, indicating the potential to surpass $100 in the mid-2030s.
Current price is $26.75 and market cap is $13.82B.
The 30-day range is $22.35 to $32.02. The stock has an annualized volatility of 50%.
Baxter International Inc. Community Discussion
0Share your Baxter International Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.